0000000000588372

AUTHOR

Carl J. Lavie

showing 39 related works from this author

Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?

2020

Abstract Although some demographic, clinical and environmental factors have been associated with a higher risk of developing coronavirus disease 2019 (COVID-19) and progressing towards severe disease, altogether these variables do not completely account for the different clinical presentations observed in patients with comparable baseline risk, whereby some subjects may remain totally asymptomatic, whilst others develop a very aggressive illness. Some predisposing genetic backgrounds can hence potentially explain the broad inter-individual variation of disease susceptibility and/or severity. It has been now clearly established that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2…

0301 basic medicinereceptorClinical BiochemistryPopulationPneumonia ViralAdipose tissueInflammationPeptidyl-Dipeptidase AAsymptomaticViruspolymorphism03 medical and health sciencesBetacoronavirus0302 clinical medicineProtein DomainsFibrosismedicineHumans030212 general & internal medicineeducationGenePandemicseducation.field_of_studyPolymorphism Geneticbusiness.industrySARS-CoV-2Biochemistry (medical)COVID-19General Medicineangiotensinmedicine.diseaseenzyme030104 developmental biologyCOVID-19 angiotensin enzyme polymorphism receptorImmunologyAngiotensin-converting enzyme 2Spike Glycoprotein CoronavirusReceptors VirusAngiotensin-Converting Enzyme 2medicine.symptombusinessCoronavirus InfectionsProtein Binding
researchProduct

Survival Benefit of Obese Patients With Pulmonary Embolism.

2018

To investigate the impact of obesity and underweight on adverse in-hospital outcomes in pulmonary embolism (PE).Patients diagnosed as having PE based on International Statistical Classification of Diseases and Related Health Problems, 10th Revision, German Modification code I26 in the German nationwide inpatient database were stratified for obesity, underweight, and normal weight/overweight (reference group) and compared regarding adverse in-hospital outcomes.From January 1, 2011, through December 31, 2014, 345,831 inpatients (53.3% females) 18 years and older were included in this analysis; 8.6% were obese and 0.5% were underweight. Obese patients were younger (67.0 vs 73.0 years), were mo…

Malemedicine.medical_specialtymedicine.medical_treatmentEmbolectomyOverweightThinnessInterquartile rangeInternal medicinemedicineHumansHospital MortalityObesitySurvival rateAgedAged 80 and overbusiness.industryMortality rateGeneral MedicineMiddle Agedmedicine.diseasePulmonary embolismSurvival RateFemalemedicine.symptomUnderweightbusinessPulmonary EmbolismBody mass indexMayo Clinic proceedings
researchProduct

Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection

2021

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)medicine.medical_treatmentCOVID-19Body Mass Index Intubation Death SARS-CoV-2General MedicineVirologyBody Mass IndexDeathRisk FactorsIntubation IntratrachealInternal MedicineHumansMedicineIntubationIntubationbusinessBody mass indexRetrospective StudiesAnnals of Internal Medicine
researchProduct

Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the Internationa…

2021

Inflammation is a marker of arterial disease stemming from cholesterol-dependent to -independent molecular mechanisms. In recent years, the role of inflammation in atherogenesis has been underpinned by pharmacological approaches targeting systemic inflammation that have led to a significant reduction in cardiovascular disease (CVD) risk. Although the use of nutraceuticals to prevent CVD has largely focused on lipid-lowering (e.g, red-yeast rice and omega-3 fatty acids), there is growing interest and need, especially now in the time of coronavirus pandemic, in the use of nutraceuticals to reduce inflammatory markers, and potentially the inflammatory CVD burden, however, there is still not en…

RMArterial diseaseAnti-Inflammatory AgentsInflammationDiseaseC-reactive protein ; cardiovascular disease ; inflammation ; nutraceuticals ; omega-3 ; position paper ; red-yeast rice030204 cardiovascular system & hematologyBioinformaticsSystemic inflammationC-reactive protein03 medical and health sciences0302 clinical medicineNutraceuticalMedicineHumansPosition paper030212 general & internal medicineUncategorizedOmega-3InflammationbiologyC-reactive protein; Cardiovascular disease; Inflammation; Nutraceuticals; Omega-3; Position paper; Red-yeast rice; Anti-Inflammatory Agents; Biomarkers; Cardiovascular Diseases; Humans; Inflammation; Lipids; Dietary SupplementsVascular inflammationbusiness.industryC-reactive proteinC-reactive protein Cardiovascular disease Inflammation Nutraceuticals Omega-3 Position paper Red-yeast rice Anti-Inflammatory Agents Biomarkers Cardiovascular Diseases Humans Inflammation Lipids Dietary SupplementsCardiovascular diseaseRed-yeast riceLipidsCardiovascular DiseasesDietary Supplementsbiology.proteinPosition paperNutraceuticalsNutraceuticalmedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersProgress in cardiovascular diseases
researchProduct

COVID-19 and obesity: links and risks

2020

Applicable to the fields of endocrinology, as well as for specialists in cardiovascular disease (CVD), obesity has numerous cardiometabolic unfavorable consequences. Obesity is by far the leading c...

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Endocrinology Diabetes and MetabolismPneumonia ViralMEDLINEseverityDiseasePeptidyl-Dipeptidase ACOVID-19; Obesity; mortality; prognosis; severityCOVID-19BetacoronavirusMetabolic DiseasesRisk FactorsPandemicHumansMedicineObesityIntensive care medicinePandemicsbiologySARS-CoV-2business.industryViral EpidemiologyCOVID-19biology.organism_classificationmedicine.diseaseObesitymortalityPneumoniaAngiotensin-Converting Enzyme 2prognosisCoronavirus InfectionsbusinessBetacoronavirus
researchProduct

Prognostic value of troponin I in atrial fibrillation

2021

To evaluate whether circulating cardiac troponin I (cTnI) levels are associated with worst outcomes in patients with atrial fibrillation (AF).Consecutive patients visiting the emergency room (ER) with a new episode of a previously diagnosed AF or a new diagnosis of AF during ER admission between January 1st, 2010 and December 31st, 2015, were enrolled in the study (n = 2617). After applying exclusion criteria and eliminating repeated episodes, 2013 patients were finally included. Of these, 1080 patients with at least one cTnI measurement in the ER were selected and classified into 4 groups according to cTnI quartiles: Q1 (n = 147) cTnI10 ng/L (Group 1); Q2 (n = 254): 10-19 ng/L (Group 2); Q…

Malemedicine.medical_specialtyTime FactorsHeart failureComorbidity030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsInternal medicineTroponin ImedicineClinical endpointAtrial fibrillation Emergency Heart failure Mortality TroponinsTroponinsHumans030212 general & internal medicineRisk factorMortalityAdverse effectAgedRetrospective StudiesAged 80 and overbiologybusiness.industryTroponin IAtrial fibrillationMiddle AgedPrognosismedicine.diseaseTroponinAtrial fibrillationQuartileHeart failureEmergencybiology.proteinFemaleEmergency Service HospitalCardiology and Cardiovascular MedicinebusinessBiomarkers
researchProduct

Consumer wearable technologies to identify and monitor exercise-related arrhythmias in athletes

2020

PURPOSE OF REVIEW: The aim of this study was to synthesize the current evidence supporting and against the use of wearable devices to detect underlying heart conditions in athletes and the most significant limitations. RECENT FINDINGS: Although several large studies have been conducted to evaluate the ability of wearables devices to identify atrial fibrillation among the general population, no studies evaluating their ability to detect other exercise-related arrhythmias in athletes are very sparse. Most of the studies or case reports are focused on the wearables' reliability and accuracy compared with standard ECG. Only small studies evaluating the accuracy of one wearable device in athlete…

education.field_of_studymedicine.medical_specialtybiologybusiness.industryAthletesPopulationWearable computer030204 cardiovascular system & hematologybiology.organism_classification03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationMedicineDiagnostic data030212 general & internal medicineCardiology and Cardiovascular MedicinebusinesseducationWearable technologyStandard ECGHealthcare systemCurrent Opinion in Cardiology
researchProduct

Diabetes mellitus association with coronavirus disease 2019 ( COVID ‐19) severity and mortality: A pooled analysis

2020

Highlights There are ~ 2-fold increased odds of severe coronavirus disease 2019 (COVID-19) and a ~ 2-fold increased risk of odds of mortality in patients with history of diabetes mellitus compared to those without diabetes mellitus. Patients with a history of diabetes mellitus should be closely monitored if they get infected with COVID-19. Results of meta-analysis showing association of diabetes mellitus with severity (Panel A) of disease and mortality (Panel B) in coronavirus disease 2019 (COVID-19) patients.

AdultMalemedicine.medical_specialtyTime FactorsAdolescentendocrine system diseasesEndocrinology Diabetes and MetabolismPneumonia Viralcoronavirus030209 endocrinology & metabolismDisease030204 cardiovascular system & hematologymedicine.disease_causeRisk AssessmentSeverity of Illness IndexCOVID-19 coronavirus diabetes mellitusBetacoronavirusYoung Adult03 medical and health sciences0302 clinical medicineCOVID‐19Risk FactorsCause of DeathInternal medicineDiabetes mellitusPandemicSeverity of illnessResearch LetterHumansMedicineYoung adultPandemicsAgedCoronavirusCause of deathAged 80 and overSARS-CoV-2business.industryCOVID-19Middle AgedPrognosismedicine.diseaseResearch LettersHost-Pathogen Interactionsdiabetes mellitusFemaleCoronavirus InfectionsbusinessRisk assessmentJournal of Diabetes
researchProduct

Cross-Country Skiing and Running’s Association with Cardiovascular Events and All-Cause Mortality:A Review of the Evidence

2019

A large body of evidence demonstrates positive, graded effects of PA on cardiovascular disease (CVD) morbidity and mortality with increasing intensity compared with lower PA intensity. Running is often designated as a high-intensity PA with substantial evidence supporting its health benefits. Cross-country skiing is among the most demanding aerobic endurance exercises and requires engaging the upper- and lower-body. Cross-country skiing is often regarded as high-intensity PA, which has been associated with significant health benefits. However, a robust body of evidence identifying the dose-response relation between cross-country skiing volume and health outcomes is sparse. Therefore, this r…

medicine.medical_specialtyhigh-intensity physical activityDisease030204 cardiovascular system & hematologyHealth benefitsliikuntaRisk AssessmentRunningjuoksu03 medical and health sciences0302 clinical medicineskiingRisk FactorsSkiingcardiovascular diseasemedicinerunningHumansAerobic exercise030212 general & internal medicineMortalityIntensive care medicineAdverse effectCross countryexercisebusiness.industryPhysical activityCardiorespiratory fitnesshiihtoBlood pressureCardiorespiratory FitnessCardiovascular DiseasesAthletic InjuriesPhysical Endurancesydän- ja verisuonitauditCardiology and Cardiovascular MedicinebusinessAll cause mortalityfyysinen aktiivisuus
researchProduct

In Reply – Association of Renin Angiotensin System Blockers with Outcomes in Patients With COVID-19

2020

2019-20 coronavirus outbreakmedicine.medical_specialtyhypertensionCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Renin-Angiotensin COVID-19 hypertensionCOVID-19General MedicineRenin-Angiotensin SystemBetacoronavirusInternal medicineRenin–angiotensin systemHumansMedicineIn patientCoronavirus InfectionsbusinessPandemicsRenin-AngiotensinLetter to the EditorMayo Clinic Proceedings
researchProduct

Fit Is It in COVID-19, Future Pandemics, and Overall Healthy Living.

2021

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINECOVID-19General MedicineVirologyEditorialPhysical FitnessPandemicMedicineHumansHealthy LifestylebusinessPandemicsMayo Clinic proceedings
researchProduct

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Dis…

2020

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, is being defined as the worst pandemic disease of modern times. Several professional health organizations have published position papers stating that there is no evidence to change the use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in the management of elevated blood pressure in the context of avoiding or treating COVID-19 infection. In this article, we review the evidence on the relationship between the renin-angiotensin-aldosterone system and COVID-19 infection. In agreement with current guidelines, patients with hypertension should continue taki…

medicine.medical_specialtyAngiotensin-Converting Enzyme030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusmedicinecardiovascular diseases030212 general & internal medicineAdverse effectbiologyAngioedemabusiness.industryCOVID-19Angiotensin-converting enzymeGeneral Medicinemedicine.diseaseCoronavirusBlood pressureAngiotensin-Converting Enzyme Coronavirus COVID-19Heart failureAngiotensin-converting enzyme 2biology.proteinmedicine.symptombusinessKidney diseaseMayo Clinic Proceedings
researchProduct

Role of non-coding RNAs as biomarkers of deleterious cardiovascular effects in sepsis.

2021

The mechanisms occurring during sepsis that produce an increased risk of cardiovascular (CV) disease (CVD) are poorly understood. Even less information exists regarding CV dysfunction as a complication of sepsis, particularly for sepsis-induced cardiomyopathy. However, recent research has demonstrated that non-coding RNAs, including microRNAs, long non-coding RNAs, and circular RNAs, play a crucial role in genetic reprogramming, gene regulation, and inflammation during the development of CVD. Here we describe experimental findings showing the importance of non-coding RNAs mediating relevant mechanisms underlying CV dysfunction after sepsis, so contributing to sepsis-induced cardiomyopathy. …

Regulation of gene expressionbusiness.industryCardiomyopathyInflammationDiseaseRNA Circularmedicine.diseaseBioinformaticsRisk AssessmentSepsisMicroRNAsHeart Disease Risk FactorsSepsismicroRNAmedicineAnimalsHumansRNA Long NoncodingEpigeneticsmedicine.symptomCardiology and Cardiovascular MedicinebusinessCardiomyopathiesReprogrammingBiomarkersProgress in cardiovascular diseases
researchProduct

Cardiac Injury in COVID-19–Echoing Prognostication∗

2020

Background Myocardial injury is frequent among patients hospitalized with coronavirus disease-2019 (COVID-19) and is associated with a poor prognosis. However, the mechanisms of myocardial injury remain unclear and prior studies have not reported cardiovascular imaging data. Objectives This study sought to characterize the echocardiographic abnormalities associated with myocardial injury and their prognostic impact in patients with COVID-19. Methods We conducted an international, multicenter cohort study including 7 hospitals in New York City and Milan of hospitalized patients with laboratory-confirmed COVID-19 who had undergone transthoracic echocardiographic (TTE) and electrocardiographic…

Malemyocaardial injuryCoronary AngiographyElectrocardiographyPandemicVentricular Dysfunctionechocardiographymyocardial injuryOriginal Investigationechocardiography; inflammation; myocaardial injury; SARS-CoV-2; troponin; COVID-19COVID-19 coronavirus disease-2019biologyViral EpidemiologytroponinHeartMiddle AgedRV right ventriclemyocardial infarctionItalyTTE transthoracic echocardiographyFemaleCardiology and Cardiovascular MedicineCoronavirus InfectionsEditorial Comment2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralAKI acute kidney injuryECG electrocardiographyBetacoronavirusmedicineHumansPandemicsARDS acute respiratory distress syndromeIQR interquartile rangeAgedRetrospective Studiesbusiness.industrySARS-CoV-2MyocardiumCOVID-19medicine.diseasebiology.organism_classificationVirologyCOVID-19 Drug TreatmentCI confidence intervalOR odds ratioPneumoniaLV left ventricleinflammationACS acute coronary syndromeNew York CitybusinessCoronavirus InfectionsBetacoronavirusBiomarkersJournal of the American College of Cardiology
researchProduct

Personal activity intelligence and mortality : Data from the Aerobics Center Longitudinal Study

2021

Importance Personal activity intelligence (PAI) is a novel activity metric that can be integrated into self-assessment heart rate devices, and translates heart rate variations during exercise into a weekly score. Previous studies relating to PAI have been conducted in the same populations from Norway where the PAI metric has been derived, limiting generalizability of the results. Objective To test whether PAI is associated with total and cause-specific mortality in a large cohort from the United States. Design Aerobics Center Longitudinal Study (ACLS) - a prospective cohort between January 1974 and December 2002 with a mean follow-up of 14.5 years. Setting Population-based. Participants 56,…

kuolleisuusLongitudinal studymedicine.medical_specialtyPopulationphysical activityDisease030204 cardiovascular system & hematologyLower risk03 medical and health sciences0302 clinical medicineInterquartile rangecardiovascular diseaseInternal medicineHeart rateMedicine030212 general & internal medicineProspective cohort studyeducationeducation.field_of_studyexerciseactivity metricbusiness.industrykuntoliikuntaHazard ratiomortalitymittarit (mittaus)sydän- ja verisuonitauditCardiology and Cardiovascular Medicinebusinessfyysinen aktiivisuus
researchProduct

In Reply - Cardiorespiratory Fitness Attenuates the Impact of Risk Factors Associated With COVID-19 Hospitalization

2021

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Physical fitnessMEDLINECOVID-19Cardiorespiratory fitnessGeneral MedicineHospitalizationCardiorespiratory FitnessPhysical FitnessRisk FactorsEmergency medicinePandemicmedicineHumansHealthy LifestylebusinessPandemicsLetter to the EditorMayo Clinic Proceedings
researchProduct

Critical role of cardiac magnetic resonance in the diagnosis of left-dominant arrhythmogenic cardiomyopathy: A paradigmatic case in a recreational mi…

2021

medicine.medical_specialtySports cardiologyCardiac magnetic resonancebusiness.industryCardiomyopathyCase Reportmedicine.diseaseDefibrillatorInternal medicineDiagnosisCardiologyMedicineCardiology and Cardiovascular MedicinebusinessCardiac magnetic resonanceLEFT DOMINANTArrhythmiaHeartRhythm Case Reports
researchProduct

Running away from cardiovascular disease at the right speed: The impact of aerobic physical activity and cardiorespiratory fitness on cardiovascular …

2020

Higher levels of physical activity (PA) and cardiorespiratory fitness (CRF) are associated with lower risk of incident cardiovascular disease (CVD). However, the relationship of aerobic PA and CRF with risk of atherosclerotic CVD outcomes and heart failure (HF) seem to be distinct. Furthermore, recent studies have raised concerns of potential toxicity associated with extreme levels of aerobic exercise, with higher levels of coronary artery calcium and incident atrial fibrillation noted among individuals with very high PA levels. In contrast, the relationship between PA levels and measures of left ventricular structure and function and risk of HF is more linear. Thus, personalizing exercise …

medicine.medical_specialtyphysical activityheart failureDisease030204 cardiovascular system & hematologyLower risksydämen vajaatoimintaCoronary artery disease03 medical and health sciences0302 clinical medicinepreventionInternal medicinemedicineAerobic exerciseatrial fibrillation030212 general & internal medicineSubclinical infectionkuntoliikuntabusiness.industryAtrial fibrillationCardiorespiratory fitnessaerobinen harjoittelueteisvärinämedicine.diseasefitnessfyysinen kuntoHeart failuresydän- ja verisuonitauditCardiologyCardiology and Cardiovascular Medicinebusinesscoronary artery diseasefyysinen aktiivisuusProgress in Cardiovascular Diseases
researchProduct

In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme I…

2020

2019-20 coronavirus outbreakAngiotensinsCoronavirus disease 2019 (COVID-19)Pneumonia ViralAngiotensin-Converting EnzymeACE2InflammationAngiotensin-Converting Enzyme InhibitorsPharmacologyArticleAngiotensin Receptor AntagonistsBetacoronavirusRenin–angiotensin systemmedicineHumansPandemicsAntihypertensive AgentsInflammationAngiotensin Receptor Antagonistsbiologybusiness.industrySARS-CoV-2COVID-19Angiotensin-converting enzymeGeneral MedicineCoronavirusAngiotensin-converting enzyme 2biology.proteinAngiotensin Receptor BlockersAngiotensin-Converting Enzyme COVID-19 coronavirus ACE2medicine.symptombusinessCoronavirus InfectionsCoronavirus InfectionsMayo Clinic proceedings
researchProduct

Special Article - Exercise-induced right ventricular injury or arrhythmogenic cardiomyopathy (ACM): The bright side and the dark side of the moon.

2020

There is still debate on the range of normal physiologic changes of the right ventricle or ventricular (RV) function in athletes. Genetic links to arrhythmogenic cardiomyopathy (ACM) are well-established. There is no current consensus on the importance of extensive exercise and exercise-induced injury to the RV. During the intensive exercise of endurance sports, the cardiac structures adapt to athletic load over time. Some athletes develop RV cardiomyopathy possibly caused by genetic predisposition, whilst others develop arrhythmias from the RV. Endurance sports lead to increased volume and pressure load in both ventricles and increased myocardial mass. The extent of volume increase and cha…

medicine.medical_specialtySports medicineVentricular Dysfunction RightCardiomyopathy030204 cardiovascular system & hematologyRisk AssessmentBoth ventriclesSudden cardiac death03 medical and health sciences0302 clinical medicineInternal medicinemedicineGenetic predispositionHumansGenetic Predisposition to Disease030212 general & internal medicineCardiomegaly Exercise-InducedPathologicalExerciseArrhythmogenic Right Ventricular DysplasiabiologyVentricular Remodelingbusiness.industryAthletesMyocardiummedicine.diseasebiology.organism_classificationAdaptation PhysiologicalFibrosismedicine.anatomical_structureDeath Sudden CardiacVentricleAthletesHeart Disease Risk FactorsCardiologyPhysical EnduranceVentricular Function RightCardiology and Cardiovascular MedicinebusinessProgress in cardiovascular diseases
researchProduct

Sex-specific differences drive temporal trends and outcomes of patients hospitalized for heart failure in Germany

2020

Despite remarkable improvements in treatment of cardiovascular disease, heart failure (HF) is still characterized by high mortality rate. Sex-specific differences in HF have been described, but underlying reasons are widely unexplored.The nationwide German inpatient sample (2005-2016) was used for this sex-specific analyses. Temporal trends on hospitalizations, mortality, and treatments were analysed and independent predictors of adverse outcomes identified.The analysis comprises 4,538,977 hospitalizations due to HF (52.0%women) in Germany (2005-2016). Although women were older (median 82(IQR75-87) vs.76(69-82),P  0.001), coronary artery disease (CAD, 50.3% vs. 30.7%,P  0.001) was more prev…

Malemedicine.medical_specialtyTime FactorsDatabases FactualAdverse outcomesMEDLINEDisease030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciencesSex Factors0302 clinical medicineGermanyInternal medicineCase fatality ratePrevalencemedicineHumansHospital Mortality030212 general & internal medicineHealthcare DisparitiesAgedAged 80 and overHeart Failurebusiness.industryIncidenceMortality rateIncidence (epidemiology)Health Status Disparitiesmedicine.diseaseSex specificHospitalizationOutcome and Process Assessment Health CareTreatment OutcomeHeart Disease Risk FactorsHeart failureFemaleCardiology and Cardiovascular MedicinebusinessProgress in Cardiovascular Diseases
researchProduct

Atrial fibrillation in athletes and non-athletes: evidence of different causative mechanisms

2021

medicine.medical_specialtybiologybusiness.industryAthletesMEDLINEAtrial fibrillationGeneral Medicinemedicine.diseasebiology.organism_classificationInternal medicineMedicineRadiology Nuclear Medicine and imagingCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal - Cardiovascular Imaging
researchProduct

Cardiac magnetic resonance in the diagnosis of the unusually detected acute myocarditis in the young people: a case report

2021

Myocarditis is among the causes of arrhythmic sudden cardiac death (SCD) in young athletes, with viral infection being the most common cause worldwide. Myocarditis recently has been reported as one of the cardiac complications of coronavirus disease 2019 (COVID-19) in athletes. Here we present a case of a 20-year-old male recreational soccer player with an episode of loss of consciousness in the context of respiratory infection. The patient reports having woken up with symptoms of an upper respiratory tract infection, and after playing a soccer match, he developed dizziness and a headache. He then suffered vasovagal syncope without loss of sphincter control. Physical examination, heart ausc…

medicine.medical_specialtyMyocarditismedicine.diagnostic_testbusiness.industryRespiratory infectionPhysical examinationContext (language use)Case ReportGeneral Medicinemedicine.diseaseSudden cardiac deathEdemaInternal medicineHeart failuremedicineCardiologycardiovascular diseasesmedicine.symptombusinessVasovagal syncope
researchProduct

Fit Is It for Cardiovascular Disease Prediction, Prevention, and Treatment

2021

medicine.medical_specialtyCardiorespiratory FitnessCardiovascular DiseasesRisk Factorsbusiness.industrymedicineMEDLINEHumansDiseaseCardiology and Cardiovascular MedicineIntensive care medicinebusinessRisk AssessmentCanadian Journal of Cardiology
researchProduct

Does abdominal obesity influence immunological response to SARS-CoV-2 infection?

2021

Several hundred studies, 40 systematic reviews, and nearly 20 meta-analyses had been published by early 2021, confirming an increased need for medical services for people living with overweight or ...

Coronavirus disease 2019 (COVID-19)Endocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)severityOverweightImmune systemCOVID-19 Obesityimmune functionprognosis severitymedicineHumansObesityAbdominal obesityimmune functionbusiness.industrySARS-CoV-2COVID-19medicine.diseaseObesityMedical servicesSystematic reviewEditorialObesity AbdominalImmunologyprognosismedicine.symptombusinessResearch Article
researchProduct

Do Antioxidant Vitamins Prevent Exercise-Induced Muscle Damage? A Systematic Review

2020

Free radicals produced during exercise play a role in modulating cell signaling pathways. High doses of antioxidants may hamper adaptations to exercise training. However, their benefits are unclear. This review aims to examine whether vitamin C (VitC) and/or vitamin E (VitE) supplementation (SUP) prevents exercise-induced muscle damage. The PubMed, Web of Science, Medline, CINAHL, and SPORTDiscus databases were searched, and 21 articles were included. Four studies examined the effects of acute VitC SUP given pre-exercise: in one study, lower CK levels post-exercise was observed; in three, no difference was recorded. In one study, acute VitE SUP reduced CK activity 1 h post-exercise in condi…

antioxidant vitaminsPhysiologyStrength trainingmedicine.medical_treatmentClinical Biochemistryvitamin CAntioxidantesMúsculosReviewvitamin EMuscle damagePharmacologyBiochemistryVitaminas03 medical and health sciences0302 clinical medicinemuscle damageEndurance trainingMedicineVitaminaantioxidant vitamins; muscle damage; vitamin C; vitamin EMolecular BiologyVitamin Cbiologybusiness.industryVitamin Elcsh:RM1-950030229 sport sciencesCell BiologyHypoxia (medical)Antioxidant vitaminslcsh:Therapeutics. Pharmacologybiology.proteinCreatine kinasemedicine.symptombusinessEnfermedad030217 neurology & neurosurgery
researchProduct

Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Pneumonia ViralMEDLINEBetacoronavirusRisk FactorsInternal medicinePandemicAtrial FibrillationmedicineHumansRisk factorPandemicsbiologybusiness.industrySARS-CoV-2Discussion ForumCOVID-19Atrial fibrillationmedicine.diseasebiology.organism_classificationPrognosisItalyCardiovascular DiseasesCardiology and Cardiovascular MedicinebusinessCoronavirus InfectionsCoronavirus InfectionsBetacoronavirusEuropean heart journal
researchProduct

Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk:An International …

2017

Hypertension is a leading risk factor for disease burden globally. An unresolved question is whether grade 1 hypertension (140-159/90-99. mm. Hg) with low (cardiovascular mortality <1% at 10 years) to moderate (cardiovascular mortality ≥1% and <5% at 10 years) absolute total cardiovascular risk (CVR) should be treated with antihypertensive agents. A virtual international consultation process was undertaken to summarize the opinions of select experts. After holistic analysis of all epidemiological, clinical, psychosocial, and public health elements, this consultation process reached the following consensus in hypertensive adults aged <80 years: (1) The question of whether drug treat…

AdultMaleRiskmedicine.medical_specialtyPediatricsEvidence-based practiceHeart Diseasesmedicine.drug_classMEDLINE030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineHypertension/complicationsEpidemiologymedicineHumans030212 general & internal medicineRisk factorAntihypertensive drugAntihypertensive AgentsDisease burdenAntihypertensive Agents/therapeutic usebusiness.industryPublic healthHeart Diseases/etiologyGeneral MedicineHypertensionFemaleCardiology and Cardiovascular MedicinebusinessPsychosocial
researchProduct

Exercise effects on cardiovascular disease: from basic aspects to clinical evidence.

2021

Contains fulltext : 283453.pdf (Publisher’s version ) (Closed access) Cardiovascular (CV) disease (CVD) remains the leading cause of major morbidity and CVD- and all-cause mortality in most of the world. It is now clear that regular physical activity (PA) and exercise training (ET) induces a wide range of direct and indirect physiologic adaptations and pleiotropic benefits for human general and CV health. Generally, higher levels of PA, ET, and cardiorespiratory fitness (CRF) are correlated with reduced risk of CVD, including myocardial infarction, CVD-related death, and all-cause mortality. Although exact details regarding the ideal doses of ET, including resistance and, especially, aerobi…

education.field_of_studymedicine.medical_specialtyPhysiologybusiness.industryPopulationVascular damage Radboud Institute for Health Sciences [Radboudumc 16]Cardiorespiratory fitnessDiseasemedicine.diseaseCardiorespiratory FitnessEndurance trainingClinical evidenceCardiovascular DiseasesRisk FactorsPhysiology (medical)medicineHumansMyocardial infarctionCardiology and Cardiovascular MedicineeducationPhysiologic AdaptationsAdverse effectIntensive care medicinebusinessExerciseCardiovascular Research
researchProduct

Vitamin D and Cardiovascular Health

2021

The principal source of vitamin D in humans is its biosynthesis in the skin through a chemical reaction dependent on sun exposure. In lesser amounts, the vitamin can be obtained from the diet, mostly from fatty fish, fish liver oil and mushrooms. Individuals with vitamin D deficiency, defined as a serum level of 25 hydroxyvitamin D < 20 ng/dl, should be supplemented. Vitamin D deficiency is a prevalent global problem caused mainly by low exposure to sunlight. The main role of 1,25 dihydroxyvitamin D is the maintenance of calcium and phosphorus homeostasis. However, vitamin D receptors are found in most human cells and tissues, indicating many extra-skeletal effects of the vitamin, particula…

0301 basic medicineVitaminmedicine.medical_specialtyVitamina DEnfermedad cardiovascularchemistry.chemical_element030209 endocrinology & metabolismCalciumCritical Care and Intensive Care Medicinemedicine.disease_causevitamin D deficiencyNitric oxide03 medical and health scienceschemistry.chemical_compound0302 clinical medicineImmune systemInternal medicineHipertensiónmedicineVitamin D and neurologyHumansSupplementsVitamin D030109 nutrition & dieteticsNutrition and DieteticsEnfermedad coronariabusiness.industryEndothelial functionVitamin D Deficiencymedicine.diseaseCardiovascular diseaseCoronary heart diseaseEndocrinologyDietéticachemistryCardiovascular DiseasesNutriciónHypertensionNarrative ReviewbusinessHomeostasisOxidative stress
researchProduct

Coronavirus Disease 2019–Associated Coagulopathy

2021

Patients with the severe form of coronavirus disease 2019 (COVID-19) have been frequently found to suffer from both arterial and venous thrombotic events due to the perpetuation of a hypercoagulable state. This phenomenon, termed COVID-19-associated coagulopathy (CC), is now considered a major component of the pathophysiology of this novel infectious disease, leading to widespread thrombosis. While at first, the vascular insults may be limited to the pulmonary microvasculature, as the disease progresses, systemic involvement occurs, culminating in distant organ thrombosis and multi-organ dysfunction syndrome. In this review article, we discuss recent insights into the pathophysiologic mecha…

ARDSPAI-1 Plasminogen Activator Inhibitor 1VTE venous thromboembolismDiseaseReview030204 cardiovascular system & hematologyCoronavirus Disease 20190302 clinical medicineCoagulopathy030212 general & internal medicineDIC disseminated intravascular coagulationDisseminated intravascular coagulationCOVID-19 Coronavirus disease 2019DVT deep vein thrombosisGeneral MedicineBlood Coagulation DisordersThrombosisICU intensive care unitTMA thrombotic microangiopathyDisease ProgressionCoronavirus Disease 2019 COVID-19 CoagulopathyVWF von Willebrand factormedicine.medical_specialtyThrombotic microangiopathyACE2 angiotensin-converting enzyme 2SARS-CoV-2 severe acute respiratory syndrome coronavirus 203 medical and health sciencesmedicineCoagulopathyHumansIntensive care medicineLY30 lysis at 30 minutesARDS acute respiratory distress syndromeHemostasisNO nitric oxideCoagulationbusiness.industrySARS-CoV-2COVID-19Thrombosismedicine.diseasetPA tissue plasminogen activatorReview articleIL interleukinCoronavirusVascular DisorderPE pulmonary embolismTF tissue factorbusinessCC COVID-associated coagulopathyMayo Clinic Proceedings
researchProduct

Obesity paradox in peripheral artery disease

2019

Background & aims: Previous studies have suggested an obesity survival paradox in patients with peripheral artery disease (PAD). We investigated the influence of obesity and underweight on adverse in-hospital outcomes in PAD. Methods: Patients diagnosed with PAD based on ICD-code I70.2 of the German nationwide database were stratified for obesity, underweight and a reference group with normal-weight/over-weight and compared regarding adverse in-hospital outcomes. Results: Between 01/2005-12/2015, 5,611,484 inpatients (64.8% males) were diagnosed with PAD; of those, 8.9% were coded with obesity and 0.3% with underweight. Obese patients were younger (70 (IQR 63/76) vs. 73 (66/80) years, P < 0…

Male0301 basic medicinemedicine.medical_specialtyArterial diseasemedicine.medical_treatment030209 endocrinology & metabolismDiseaseCritical Care and Intensive Care MedicineCohort StudiesPeripheral Arterial Disease03 medical and health sciences0302 clinical medicineThinnessGermanyInternal medicineHumansMedicineHospital MortalityObesityAged030109 nutrition & dieteticsNutrition and Dieteticsbusiness.industryCancerMiddle Agedmedicine.diseaseObesityAmputationFemaleUnderweightmedicine.symptombusinessLower mortalityObesity paradoxClinical Nutrition
researchProduct

Cardiorespiratory Fitness and the Risk of Serious Ventricular Arrhythmias: A Prospective Cohort Study.

2019

Cardiorespiratory fitness (CRF) is an established risk factor for cardiovascular disease outcomes. However, the relationship of CRF with risk of ventricular arrhythmias (VAs) is unknown. We aimed to assess the prospective association of CRF with the risk of serious VAs. Cardiorespiratory fitness, as measured by maximal oxygen uptake, was assessed using a respiratory gas exchange analyzer in 2299 middle-aged men in the Kuopio Ischemic Heart Disease prospective cohort. We corrected for within-person variability in CRF levels using data from repeated measurements 11 years apart. During median follow-up of 25.3 years (interquartile range, 18.7-27.2 years), 73 serious VAs were recorded. The age-…

rytmihäiriötAdultMalemedicine.medical_specialtyRegression dilutionRisk AssessmentOxygen ConsumptionInterquartile rangeRisk FactorsInternal medicineMedicineHumansregression dilutionLongitudinal StudiesProspective StudiesRisk factorProspective cohort studyProportional Hazards Modelscardiorespiratory fitnessbusiness.industryIncidenceventricular arrhythmiasHazard ratioCardiorespiratory fitnessArrhythmias Cardiacta3142General Medicineta3121Middle Agedfyysinen kuntoBlood pressurerisk factorCardiorespiratory Fitnessmaximal oxygen uptakesydän- ja verisuonitauditCardiologybusinessBody mass indexMayo Clinic proceedings
researchProduct

Impact of obesity on adverse in-hospital outcomes in patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip® procedure - R…

2019

Background and aim: The number of percutaneous edge-to-edge mitral regurgitation (MR) valve repairs with MitraClip® implantations increased exponentially in recent years. Studies have suggested an obesity survival paradox in patients with cardiovascular diseases. We investigated the influence of obesity on adverse in-hospital outcomes in patients with MitraClip® implantation. Methods and results: We analyzed data on characteristics of patients and in-hospital outcomes for all percutaneous mitral valve repairs using the edge-to-edge MitraClip®-technique in Germany 2011–2015 stratified for obesity vs. normal-weight/over-weight. The nationwide inpatient sample comprised 13,563 inpatients under…

MaleCardiac Catheterizationmedicine.medical_specialtyTime FactorsDatabases FactualEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMedicine (miscellaneous)030209 endocrinology & metabolism030204 cardiovascular system & hematologyProsthesis DesignRisk Assessment03 medical and health sciencesPostoperative Complications0302 clinical medicineRisk FactorsGermanyInternal medicineMitral valvemedicineHumansHospital MortalityObesityAgedAged 80 and overHeart Valve Prosthesis ImplantationMechanical ventilationMitral regurgitationNutrition and Dieteticsbusiness.industryMitraClipMitral Valve Insufficiencymedicine.diseasePulmonary embolismTreatment Outcomemedicine.anatomical_structureHeart Valve ProsthesisHeart failureCardiologyFemaleCardiology and Cardiovascular MedicineMitral valve regurgitationbusinessObesity paradoxNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide.

2020

Obesity has reached epidemic proportions in the United States and in much of the westernized world, contributing to considerable morbidity. Several of these obesity-related morbidities are associated with greater risk for death with coronavirus disease 2019 (COVID-19). Severe acute respiratory syndrome coronavirus 2 penetrates human cells through direct binding with angiotensin-converting enzyme 2 receptors on the cell surface. Angiotensin-converting enzyme 2 expression in adipose tissue is higher than that in lung tissue, which means that adipose tissue may be vulnerable to COVID-19 infection. Obese patients also have worse outcomes with COVID-19 infection, including respiratory failure, n…

BMI body mass indexmedicine.medical_treatmentAdipose tissue030204 cardiovascular system & hematologyCHD coronary heart diseaseHF heart failureUS United States0302 clinical medicineRAAS renin-angiotensin-aldosterone systemPandemicMedicine030212 general & internal medicineCDC Centers for Disease Control and PreventionCOVID-19 coronavirus disease 2019TNF tumor necrosis factorHFpEF HF with preserved ejection fractionCV cardiovascularGeneral MedicinePrognosisICU intensive care unitPA physical activityMetS metabolic syndromePAH pulmonary arterial hypertensionCoronavirus Infectionsmedicine.medical_specialtyAF atrial fibrillationACE angiotensin-converting enzymePneumonia ViralCVD cardiovascular diseaseSARS-CoV-2 severe acute respiratory syndrome coronavirus 2ArticleSeverity03 medical and health sciencesBetacoronavirusInternal medicineIPF idiopathic pulmonary fibrosisHumansObesityMortalityHTN hypertension or hypertensivePandemicsMechanical ventilationAng II angiotensin IIbusiness.industrySARS-CoV-2CKD chronic kidney diseaseCOVID-19T2DM type 2 diabetes mellitusmedicine.diseaseAngiotensin IIObesityIL interleukinPneumoniaRespiratory failureMetabolic syndromebusinessSNS sympathetic nervousMayo Clinic proceedings
researchProduct

CT-Determined Maximum Pulmonary Artery to Ascending Aorta Diameter Ratio in Nonsevere COVID-19 Patients

2021

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19Pulmonary ArteryDiameter ratioText miningTomography x ray computedRadiology Nuclear Medicine and imagingmedicine.arteryPulmonary arteryAscending aortaMedicineHumansRadiology Nuclear Medicine and imagingbusinessNuclear medicineLetters to the EditorTomography X-Ray ComputedAortaAcademic Radiology
researchProduct

Temporal changes in personal activity intelligence and mortality : data from the aerobics center longitudinal study

2021

Background Personal activity intelligence (PAI) is a metric developed to simplify a physically active lifestyle for the participants. Regardless of following today's advice for physical activity, a PAI score ≥100 per week at baseline, an increase in PAI score, and a sustained high PAI score over time were found to delay premature cardiovascular disease (CVD) and all-cause mortality in a large population of Norwegians. However, the association between long-term temporal change in PAI and mortality in other populations have not been investigated. Objective To test whether temporal change in PAI is associated with CVD and all-cause mortality in a large population from the United States. Method…

kuolleisuusexerciseactivity metriccardiovascular diseasesydän- ja verisuonitauditphysical activityliikuntamortalitykohorttitutkimusfyysinen aktiivisuus
researchProduct

Effect of Omega-3 Dosage on Cardiovascular Outcomes : An Updated Meta-Analysis and Meta-Regression of Interventional Trials

2021

Objectives:To quantify the effect of eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids oncardiovascular disease (CVD) prevention and the effect of dosage. Methods:This study is designed as a random effects meta-analysis and meta-regression of ran-domized control trials with EPA/DHA supplementation. This is an update and expanded analysis ofa previously published meta-analysis which covers all randomized control trials with EPA/DHAinterventions and cardiovascular outcomes published before August 2019. The outcomes includedare myocardial infarction (MI), coronary heart disease (CHD) events, CVDevents (a composite ofMI, angina, stroke, heart failure, peripheral arterial disease, sudden de…

meta-analyysiterveysvaikutuksetsydän- ja verisuonitauditomega-3 dosagecardiovascular outcomesomegarasvahapot
researchProduct

Why is COVID-19 especially impacting the African American population?

2020

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic, penetrates human cells through direct binding with ...

Coronavirus disease 2019 (COVID-19)virusesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia Viral030204 cardiovascular system & hematologymedicine.disease_causeepidemicsVirus03 medical and health sciences0302 clinical medicinePandemicmedicineHumans030212 general & internal medicinePandemicsCoronavirusoutbreakCoronavirus COVID-19 outbreak epidemicsViral Epidemiologybusiness.industryCOVID-19virus diseasesOutbreakHealth Status DisparitiesGeneral Medicinemedicine.diseaseVirologyUnited StatesBlack or African AmericanCoronavirusPneumoniaEditorialCoronavirus InfectionsbusinessAnnals of Medicine
researchProduct